Efficacy and Safety of Certolizumab Pegol for Crohn’s Disease: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Wei Da
Jinshui Zhu
Long Wang
Yunmin Lu
机构：
[1] Sixth People’s Hospital Affiliated to Shanghai Jiaotong University,Department of Gastroenterology
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Certolizumab pegol; Crohn’s disease; Gastroenterology; Meta-analysis; Remission rate; Response rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：541 / 553
页数：12
相关论文
共 50 条
  • [31] Certolizumab pegol for the treatment of Crohn's disease
    Sandborn, William J.
    Feagan, Brian G.
    Stoinov, Simeon
    Honiball, Pieter J.
    Rutgeerts, Paul
    Mason, David
    Bloomfield, Ralph
    Schreiber, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 228 - 238
  • [32] Certolizumab pegol in the treatment of Crohn's disease
    Ferrante, Marc
    Vermeire, Severine
    Rutgeerts, Paul
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (04) : 595 - 605
  • [33] Comparative efficacy and safety of combination therapy with infliximab for Crohn’s disease: a systematic review and network meta-analysis
    Bing Han
    Daiyuan Tang
    Xiaodan Lv
    Shiquan Li
    Junhua Fan
    Xiaofang Xu
    Jiatong Zhang
    Shang Xu
    Weizheng Ye
    Ziqian Huang
    Lingling Zhan
    Xiaoping Lv
    [J]. International Journal of Colorectal Disease, 38
  • [34] Certolizumab pegol for the treatment of Crohn's disease
    Baker, Danial E.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (06) : 683 - 691
  • [35] Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease
    Moja, L.
    Danese, S.
    Fiorino, G.
    Del Giovane, C.
    Bonovas, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1055 - 1065
  • [36] Comparative efficacy and safety of combination therapy with infliximab for Crohn's disease: a systematic review and network meta-analysis
    Han, Bing
    Tang, Daiyuan
    Lv, Xiaodan
    Li, Shiquan
    Fan, Junhua
    Xu, Xiaofang
    Zhang, Jiatong
    Xu, Shang
    Ye, Weizheng
    Huang, Ziqian
    Zhan, Lingling
    Lv, Xiaoping
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2023, 38 (01)
  • [37] Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
    Sansone, Alice Capogrosso
    Mantarro, Stefania
    Tuccori, Marco
    Ruggiero, Elisa
    Montagnani, Sabrina
    Convertino, Irma
    Marino, Alessandra
    Fornai, Matteo
    Antonioli, Luca
    Corona, Tiberio
    Garibaldi, Danila
    Blandizzi, Corrado
    [J]. DRUG SAFETY, 2015, 38 (10) : 869 - 888
  • [38] Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis
    Alice Capogrosso Sansone
    Stefania Mantarro
    Marco Tuccori
    Elisa Ruggiero
    Sabrina Montagnani
    Irma Convertino
    Alessandra Marino
    Matteo Fornai
    Luca Antonioli
    Tiberio Corona
    Danila Garibaldi
    Corrado Blandizzi
    [J]. Drug Safety, 2015, 38 : 869 - 888
  • [39] EFFICACY AND SAFETY OF DIFFERENT DOSES OF RISANKIZUMAB IN CROHN DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Badi, Yasra
    Hammad, Mohamed
    Mohamed, Mujtaba
    Elghezewi, Abdelwahap
    Kamal, Ibrahim
    Fathallah, Ahmed H.
    Gamal, Mohamed H.
    Ragab, Khaled M.
    Sultan, Mohamed
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S295 - S295
  • [40] Efficacy and safety of certolizumab pegol do not appear to be affected by neutralizing antibodies in patients with Crohn's disease
    Stephens, Sue
    Bloomfield, Ralph
    Devine, Donna M.
    Nesbitt, Andrew M.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S475 - S475
12345